-transparent.png){kind=logo}
On a series of thirty trephine bone marrow biopsies from patients with multiple myeloma, the authors evaluated expression of markers of cell proliferation or of its blockade (Ki-67, PCNA, topoisomerase IIa, cyclin D-1, AgNOR, and p27kip1) and markers indicating multidrug resistance (P-170 and Bcl-2). Expression of Ki-67 and of topoisomerase IIa was unfrequent. Marked positivity of PCNA was expressed in about one third of cases, negative staining was exceptional. No expression of cyclin D-1 was noted. Positivity of p27kip1 was frequent. P-170 was demonstrated in a small number of cases, Bcl-2 was strongly positive in most cases. The results characterise multiple myeloma as a tumour with low proliferation rate and, simultaneously, with high resistance to apoptosis.
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
March 2016,
Zhonghua yi xue za zhi,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
December 1995,
Bailliere's clinical haematology,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
January 2004,
Chinese medical journal,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
October 2002,
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
August 2021,
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
September 1998,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
January 2023,
Zhongguo shi yan xue ye xue za zhi,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
January 1997,
Cancer investigation,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
January 1959,
Patologia polska,
J Dusek, and
V Scudla, and
Z Kolár, and
P Riháková, and
A Hlobilová
January 2023,
Leukemia research reports,
